Gilead Sciences, Inc. (NASDAQ:GILD) is eyeing Arrowhead Research Corp (NASDAQ:ARWR) for an acquisition, sending a strong signal to the market about the company's resilience to the recent thrashing by buying out a small cap, as per rumors on the Street.